Is thalamic deep brain stimulation the right target to improve laryngeal dystonia symptoms?

The author(s) declare that financial support was received for the research and/or publication of this article. Research funding is provided by the Felgenhauer-Stiftung, Forschungspool Klinische Studien and Koln Fortune (University of Cologne), Horizon 2020 (Gondola), Medtronic (ODIS, OPEL, BeAble), and Boston Scientific. JB-K receives royalties from MedBridge Inc., and funding from the National Institutes of Health (R01DC016838, P50DC019900). JG receives funding from the National Institutes of Health (P50DC01990). FH-S receives funding from the National Institutes of Health (P50DC01990). PM receives funding from the National Institutes of Health (P50DC01990). SN is a consultant for MEGIN Inc., an advisor for Hippoclinic Inc., and receives funding from the National Institutes of Health (RF1NS100440, R01DC017091, R01AG088398, R21DC021557, R01DC021711, and P50DC019900). NS receives funding from the National Institutes of Health (R01DE030464) and receives consulting fees from Abbvie, Inc. SR receives funding from the National Institutes of Health (P50DC01990). JR receives funding from the Czech Ministry of Education, Czech Ministry of Health, Czech Technical University in Prague and Charles University and General University Hospital. GB receives funding from the Eleanor and Miles Shore Faculty Development Award, the Seth Robbins Mass General Neuroscience Transformative Scholar in Tinnitus Award, the American Academy of Otolaryngology-Head and Neck Surgery Percy Memorial Research Award, and the Renee Fleming Neuroarts Investigator Award. KS receives funding from the National Institutes of Health (R01NS088160, R01NS124228, R01DC011805, R01DC012545, R01DC019353, and P50DC01990), serves on the Scientific Advisory Board of the Tourette Association of America and the Voice Foundation.